NCT06023758
- Conditions
- HER2-positive Locally Advanced Resectable Gastric Cancer
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Clinical trial condition
HER2-positive Locally Advanced Resectable Gastric Cancer
Explore clinical trials studying HER2-positive Locally Advanced Resectable Gastric Cancer. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study